Literature DB >> 30907329

Co-Delivery Nanosystems for Cancer Treatment: A Review.

Reza Baradaran Eftekhari1, Niloufar Maghsoudnia1, Shabnam Samimi1, Ali Zamzami1, Farid Abedin Dorkoosh1,2.   

Abstract

Massive data available on cancer therapy more than ever lead our mind to the general concept that there is no perfect treatment for cancer. Indeed, the biological complexity of this disease is too excessive to be treated by a single therapeutic approach. Current delivery systems containing a specific drug or gene have their particular opportunities and restrictions. It is worth noting that a considerable number of studies suggest that single- drug delivery systems result in insufficient suppression of cancer growth. Therefore, one of the main ideas of co-delivery system designing is to enhance the intended response or to achieve the synergistic/combined effect compared to the single drug strategy. This review focuses on various strategies for co-delivery of therapeutic agents in the treatment of cancer. The primary approaches within the script are categorized into co-delivery of conventional chemotherapeutics, gene-based molecules, and plant-derived materials. Each one is explained in examples with the recent researches. In the end, a brief summary is provided to conclude the gist of the review. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Anti-cancer materials; cancer therapy; co-delivery; drug-drug; drug-gene; gene-gene; therapeuticzzm321990agents.

Mesh:

Substances:

Year:  2019        PMID: 30907329     DOI: 10.2174/2211738507666190321112237

Source DB:  PubMed          Journal:  Pharm Nanotechnol        ISSN: 2211-7385


  9 in total

1.  Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer.

Authors:  Yi-Qing Chen; Wen-Ting Zhu; Cai-Yan Lin; Zhong-Wen Yuan; Zhen-Hua Li; Peng-Ke Yan
Journal:  Int J Nanomedicine       Date:  2021-01-12

Review 2.  Dual or multiple drug loaded nanoparticles to target breast cancer stem cells.

Authors:  Yu Gao; Mingtan Tang; Euphemia Leung; Darren Svirskis; Andrew Shelling; Zimei Wu
Journal:  RSC Adv       Date:  2020-05-19       Impact factor: 4.036

3.  Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment.

Authors:  Tianyu Chen; Hui Chen; Yichun Jiang; Qi Yan; Shuling Zheng; Min Wu
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-17

Review 4.  Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review.

Authors:  Bingqian Li; Huili Shao; Lei Gao; Huan Li; Huagang Sheng; Liqiao Zhu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 5.  A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA.

Authors:  Ioana Toma; Alina Silvia Porfire; Lucia Ruxandra Tefas; Ioana Berindan-Neagoe; Ioan Tomuță
Journal:  Pharmaceutics       Date:  2022-07-16       Impact factor: 6.525

Review 6.  Pleiotropic effects of DCLK1 in cancer and cancer stem cells.

Authors:  Dibyashree Chhetri; Srinivasan Vengadassalapathy; Santhosh Venkadassalapathy; Varadharaju Balachandran; Vidhya Rekha Umapathy; Vishnu Priya Veeraraghavan; Selvaraj Jayaraman; Shankargouda Patil; Ashok Iyaswamy; Kanagaraj Palaniyandi; Dhanavathy Gnanasampanthapandian
Journal:  Front Mol Biosci       Date:  2022-09-26

Review 7.  Cyclodextrins-Peptides/Proteins Conjugates: Synthesis, Properties and Applications.

Authors:  Jakub Łagiewka; Tomasz Girek; Wojciech Ciesielski
Journal:  Polymers (Basel)       Date:  2021-05-27       Impact factor: 4.329

Review 8.  Nanogel: A Versatile Nano-Delivery System for Biomedical Applications.

Authors:  Yanlong Yin; Ben Hu; Xiao Yuan; Li Cai; Huile Gao; Qian Yang
Journal:  Pharmaceutics       Date:  2020-03-23       Impact factor: 6.321

Review 9.  The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers.

Authors:  Thomas C Chen; Clovis O da Fonseca; Daniel Levin; Axel H Schönthal
Journal:  Pharmaceutics       Date:  2021-12-16       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.